Published in Clin Transplant on May 19, 2010
Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med (2014) 7.25
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med (2011) 6.35
Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med (2011) 5.30
Cell type-specific gene expression differences in complex tissues. Nat Methods (2010) 4.75
Alemtuzumab induction in renal transplantation. N Engl J Med (2011) 4.13
Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management. Transplantation (2002) 3.41
Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20
Morbidity and mortality after living kidney donation, 1999-2001: survey of United States transplant centers. Am J Transplant (2003) 2.95
Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J Am Soc Nephrol (2008) 2.59
Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int (2011) 2.50
Preemptive kidney transplantation: the advantage and the advantaged. J Am Soc Nephrol (2002) 2.19
Survival among nocturnal home haemodialysis patients compared to kidney transplant recipients. Nephrol Dial Transplant (2009) 2.16
Donors with central nervous system malignancies: are they truly safe? Transplantation (2003) 2.12
Serum β2-microglobulin at discharge predicts mortality and graft loss following kidney transplantation. Kidney Int (2013) 2.12
Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. J Am Soc Nephrol (2010) 2.00
Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice. Crit Care Med (2006) 1.92
Malignancy after transplantation. Transplantation (2005) 1.92
Mitochondrial autophagy promotes cellular injury in nephropathic cystinosis. J Am Soc Nephrol (2009) 1.86
Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int (2002) 1.76
Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients. Kidney Int (2009) 1.68
Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection. Transplantation (2008) 1.66
Attitudes toward strategies to increase organ donation: views of the general public and health professionals. Clin J Am Soc Nephrol (2012) 1.66
ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms. Proc Natl Acad Sci U S A (2008) 1.63
Comparing living donor and deceased donor liver transplantation: A matched national analysis from 2007 to 2012. Liver Transpl (2014) 1.63
Access to kidney transplantation among the elderly in the United States: a glass half full, not half empty. Clin J Am Soc Nephrol (2010) 1.62
Impact of dialysis modality on survival after kidney transplant failure. Clin J Am Soc Nephrol (2011) 1.61
Acute dialysis risk in living kidney donors. Nephrol Dial Transplant (2012) 1.60
Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol (2006) 1.58
Pulsatile perfusion reduces the risk of delayed graft function in deceased donor kidney transplants, irrespective of donor type and cold ischemic time. Transplantation (2014) 1.56
Death and renal transplantation among Aboriginal people undergoing dialysis. CMAJ (2004) 1.56
Biological performance of mussel-inspired adhesive in extrahepatic islet transplantation. Biomaterials (2009) 1.55
Association between proximity to the attending nephrologist and mortality among patients receiving hemodialysis. CMAJ (2007) 1.53
C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection. Transplantation (2015) 1.50
Effect of prednisone versus no prednisone as part of maintenance immunosuppression on long-term renal transplant function. Clin J Am Soc Nephrol (2006) 1.50
Residence location and likelihood of kidney transplantation. CMAJ (2006) 1.49
Increased expression of cytotoxic effector molecules: different interpretations for steroid-based and steroid-free immunosuppression. Pediatr Transplant (2003) 1.48
Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures. Proc Natl Acad Sci U S A (2009) 1.47
A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation. J Exp Med (2013) 1.47
In vivo bioluminescence imaging of transplanted islets and early detection of graft rejection. Transplantation (2006) 1.46
Hand-assisted laparoscopic living-donor nephrectomy as an alternative to traditional laparoscopic living-donor nephrectomy. Am J Transplant (2002) 1.44
Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis. Transplantation (2002) 1.43
When Do DCD Donors Die?: Outcomes and Implications of DCD at a High-volume, Single-center OPO in the United States. Ann Surg (2016) 1.42
Transcriptional Perturbations in Graft Rejection. Transplantation (2015) 1.40
Temporary silastic mesh closure for adult liver transplantation: a safe alternative for the difficult abdomen. Liver Transpl (2007) 1.40
Occult herpes family viral infections are endemic in critically ill surgical patients. Crit Care Med (2003) 1.38
Extracellular matrix in pancreatic islets: relevance to scaffold design and transplantation. Cell Transplant (2009) 1.35
Intra-abdominal bacterial infection reactivates latent pulmonary cytomegalovirus in immunocompetent mice. J Infect Dis (2002) 1.31
Transcriptional analysis of the molecular basis of human kidney aging using cDNA microarray profiling. Kidney Int (2005) 1.31
Laparoscopic donor nephrectomy 1997 to 2003: lessons learned with 500 cases at a single institution. Surgery (2004) 1.28
Extracellular matrix protein-coated scaffolds promote the reversal of diabetes after extrahepatic islet transplantation. Transplantation (2008) 1.27
Differentially expressed RNA from public microarray data identifies serum protein biomarkers for cross-organ transplant rejection and other conditions. PLoS Comput Biol (2010) 1.27
An initial experience and evolution of laparoscopic hepatic resectional surgery. Surgery (2004) 1.26
De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population. Transplantation (2009) 1.25
Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection. Transplantation (2010) 1.25
Outcomes of kidney transplantation from older living donors to older recipients. Am J Kidney Dis (2008) 1.25
Polymer scaffolds as synthetic microenvironments for extrahepatic islet transplantation. Transplantation (2006) 1.23
C4d deposition in acute rejection: an independent long-term prognostic factor. J Am Soc Nephrol (2002) 1.23
Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival. Clin J Am Soc Nephrol (2008) 1.23
Anti-inflammatory peptide-functionalized hydrogels for insulin-secreting cell encapsulation. Biomaterials (2009) 1.21
Shotgun proteomics identifies proteins specific for acute renal transplant rejection. Proteomics Clin Appl (2010) 1.20
Growth factor delivery from self-assembling nanofibers to facilitate islet transplantation. Transplantation (2008) 1.20
West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death. Transplantation (2004) 1.18
Characterization of intra-graft B cells during renal allograft rejection. Kidney Int (2008) 1.17
Expression of complement components differs between kidney allografts from living and deceased donors. J Am Soc Nephrol (2009) 1.16
Proposed classification of complications after live donor nephrectomy. Urology (2006) 1.15
Policy statement of Canadian Society of Transplantation and Canadian Society of Nephrology on organ trafficking and transplant tourism. Transplantation (2010) 1.13
In vivo monitoring of pancreatic beta-cells in a transgenic mouse model. Mol Imaging (2006) 1.11
Proteasome inhibitor-based therapy for antibody-mediated rejection. Kidney Int (2012) 1.10
Self-assembling nanostructures to deliver angiogenic factors to pancreatic islets. Biomaterials (2010) 1.09
Laparoscopic donor nephrectomy vs. open live donor nephrectomy: a quality of life and functional study. Clin Transplant (2005) 1.07
Life satisfaction and adverse effects in renal transplant recipients: a longitudinal analysis. Clin Transplant (2002) 1.06
Non-HLA antibodies to immunogenic epitopes predict the evolution of chronic renal allograft injury. J Am Soc Nephrol (2012) 1.05
One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience. Transplantation (2003) 1.04
The International Registry on Hand and Composite Tissue Transplantation. Transplantation (2005) 1.03
Pretransplant evaluation of renal transplant candidates. Semin Nephrol (2002) 1.03
Biomarkers in solid organ transplantation: establishing personalized transplantation medicine. Genome Med (2011) 1.03
Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients. Transplantation (2002) 1.03
A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status. Am J Transplant (2005) 1.02
Pediatric renal transplantation: an overview and update. Curr Opin Pediatr (2010) 1.02
Treatment of polyomavirus infection in kidney transplant recipients: a systematic review. Transplantation (2010) 1.02
The Canadian kidney paired donation program: a national program to increase living donor transplantation. Transplantation (2015) 1.02
Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: comparison of early steroid withdrawal and chronic steroids. Clin Transplant (2008) 1.01
Molecular diagnostics in transplantation. Nat Rev Nephrol (2010) 1.01
Collagen IV-modified scaffolds improve islet survival and function and reduce time to euglycemia. Tissue Eng Part A (2013) 1.01
Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study. Transplantation (2003) 1.00
Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusions. Biomaterials (2011) 1.00
The proteogenomic path towards biomarker discovery. Pediatr Transplant (2008) 1.00
Proteasome inhibition for antibody-mediated rejection. Curr Opin Organ Transplant (2009) 1.00
Outcomes of dual adult kidney transplants in the United States: an analysis of the OPTN/UNOS database. Transplantation (2008) 0.99
Comparison of multiplex meta analysis techniques for understanding the acute rejection of solid organ transplants. BMC Bioinformatics (2010) 0.99
H-Y incompatibility predicts short-term outcomes for kidney transplant recipients. J Am Soc Nephrol (2009) 0.98
Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition. Transplantation (2011) 0.98
Pediatric kidney transplantation. Pediatr Clin North Am (2010) 0.98
Molecular profiling of anemia in acute renal allograft rejection using DNA microarrays. Am J Transplant (2003) 0.98
Malignant melanoma in solid transplant recipients: collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis. Arch Dermatol (2011) 0.97
Subclinical cytomegalovirus and Epstein-Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation. Pediatr Transplant (2007) 0.97
Differences in use of peritoneal dialysis and survival among East Asian, Indo Asian, and white ESRD patients in Canada. Am J Kidney Dis (2006) 0.97